Your session is about to expire
← Back to Search
Ketamine + Cognitive Training for Suicidal Behavior
Study Summary
This trial will test whether ketamine can help suicidal patients in the short and long term, and whether a computer training protocol can extend ketamine's effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 1 & 2 trial • 154 Patients • NCT03237286Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had a bad reaction or are allergic to ketamine or esketamine in the past.I am currently taking St John's Wort.I have not had electroconvulsive therapy in the last month.My doctor agrees I am a good candidate for ketamine treatment in the hospital.I do not have severe mental health issues like psychosis, mania, or dementia.I understand the study requirements and have signed the consent form.I was referred for a psychiatric evaluation due to feeling suicidal and need to be hospitalized.I am between 18 and 65 years old.I read below a 5th-grade level and prefer not to have materials read to me.You have a history of severe withdrawal symptoms or substance-induced mental health issues.
- Group 1: Ketamine + Cognitive Training
- Group 2: Ketamine + Sham Training
- Group 3: No-infusion (TAU) + Cognitive Training
- Group 4: No-infusion (TAU) + Sham Training
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this medical research accept volunteers aged 80 or older?
"Participants must be between 18 and 65 years of age to qualify for this medical trial."
To what extent can IV ketamine be detrimental to one's health?
"Based on its status as a Phase 4 trial, which is the final step before clinical approval, ketamine was assigned a safety rating of 3."
What is the primary goal of this research?
"This trial will monitor and measure suicidal behaviour, depression severity, and self-reported depression over the course of a year. Indicators include Adult Suicide Ideation Questionnaire (range: 0-150; high score=worse outcome), Montgomery Asberg Depression Rating Scale (range 0-60; high score=worse outcome) and Quick Inventory of Depressive Symptoms (range: 0-27; higher scores = worse outcome)."
Are there any openings to join this medical trial?
"Based on information published to clinicaltrials.gov, this experiment is no longer recruiting participants. The trial was first posted in March 2021 and last edited in November 2022. Despite the conclusion of recruitment for this particular study, there are still 273 other studies that require applicants at present."
Am I eligible to participate in this research trial?
"This clinical trial is recruiting 200 participants aged 18 to 65 who have attempted parasuicide. In order for a patient to qualify, they must possess the capacity to sign an informed consent document, be referred by C/L psychiatry and deemed medically suitable for intravenous ketamine treatment as judged by an authorised physician."
How many individuals have been recruited for participation in this investigation?
"At present, this clinical trial is not enrolling any new patients. The initial posting was on March 15th 2021 and the latest update occurred November 22nd 2022. If you are seeking other research opportunities, there are 168 trials for parasuicide recruiting participants and 105 studies involving Intravenous ketamine that require volunteers."
Who else is applying?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger